Logo image of JBIO

JADE BIOSCIENCES INC (JBIO) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:JBIO - US0080642061 - Common Stock

14.7 USD
0 (0%)
Last: 1/16/2026, 8:00:02 PM
14.72 USD
+0.02 (+0.14%)
After Hours: 1/16/2026, 8:00:02 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
JBIO revenue by date.JBIO revenue by date.
N/AN/AN/AN/AN/AN/AN/AN/A
EBITDA
YoY % growth
JBIO ebitda by date.JBIO ebitda by date.
-3.33M-8.89M
-166.97%
-23M
-158.72%
-53.17M
-131.17%
-81.313M
-52.93%
-74.014M
8.98%
N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
JBIO ebit by date.JBIO ebit by date.
-3.33M-8.89M
-166.97%
-23.02M
-158.94%
-53.24M
-131.28%
-81.409M
-52.91%
-74.296M
8.74%
N/A
-32.39%
N/A
-24.58%
N/A
-17.16%
N/A
81.74%
N/A
-2.68%
N/A
-2.70%
N/A
-2.73%
N/A
-2.74%
Operating Margin
JBIO operating margin by date.JBIO operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
JBIO eps by date.JBIO eps by date.
N/AN/AN/A-73.85
-28.69%
-100.80
-36.49%
-85.40
15.28%
N/A
96.52%
N/A
32.52%
N/A
2.99%
N/A
-39.37%
N/A
-13.18%
N/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.52
92.15%
-0.51
83.68%
-0.52
39.48%
-0.55
-13.79%
-0.58
-10.30%
-0.40
23.02%
-0.41
21.02%
-0.38
31.09%
-0.40
31.12%
Revenue
Q2Q % growth
N/AN/AN/AN/A
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-28.336M
-342.54%
-28.471M
-740.60%
-29.58M
-6.49%
-30.702M
-12.05%
-32.564M
-14.92%
N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.48
97.55%
-0.690.2130.18%
Q2 2025
Q2Q % growth
-0.86
97.14%
-0.44-0.42-94.83%
Q1 2025
Q2Q % growth
-3.15
89.16%
-8.575.4263.24%
Q4 2024
Q2Q % growth
-6.65
74.32%
-8.932.2825.49%
Q3 2024
Q2Q % growth
-19.60
21.13%
-20.801.205.75%
Q2 2024
Q2Q % growth
-30.10
-13.16%
-29.35-0.75-2.57%
Q1 2024
Q2Q % growth
-29.05
-23.88%
-27.31-1.74-6.37%
Q4 2023
Q2Q % growth
-25.90
-21.31%
-25.26-0.64-2.52%
Q3 2023
Q2Q % growth
-24.85
-26.79%
-24.69-0.16-0.65%
Q2 2023
Q2Q % growth
-26.60
-55.10%
-24.85-1.75-7.05%
Q1 2023
Q2Q % growth
-23.45
-48.89%
-21.42-2.03-9.48%
Q4 2022
Q2Q % growth
-21.35
-74.29%
-22.060.713.20%
Q3 2022
Q2Q % growth
-19.60
-115.38%
-17.79-1.81-10.19%
Q2 2022
Q2Q % growth
-17.15
97.94%
-16.23-0.92-5.64%
Q1 2022
Q2Q % growth
-15.75 -9.91-5.84-58.98%
Q4 2021
Q2Q % growth
-12.25 -10.98-1.27-11.59%
Q3 2021
Q2Q % growth
-9.10 -9.280.181.96%
Q2 2021
Q2Q % growth
-833.00 -5.59-827.41-14,793.30%
JBIO Yearly EPS VS EstimatesJBIO Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 -20 -40 -60 -80 -100
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-1.59% -1.24% 0% 17.19%
RevenueN/A N/A N/A N/A